These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 18328520)

  • 1. Receptor-independent, vacuolar ATPase-mediated cellular uptake of histamine receptor-1 ligands: possible origin of pharmacological distortions and side effects.
    Morissette G; Lodge R; Bouthillier J; Marceau F
    Toxicol Appl Pharmacol; 2008 Jun; 229(3):320-31. PubMed ID: 18328520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trapping of adrenergic decongestant drugs into cellular endomembrane compartments: toxicological and pharmacological consequences.
    Morissette G; Bouthillier J; Marceau F
    Int Immunopharmacol; 2007 Dec; 7(14):1869-79. PubMed ID: 18039524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intense pseudotransport of a cationic drug mediated by vacuolar ATPase: procainamide-induced autophagic cell vacuolization.
    Morissette G; Lodge R; Marceau F
    Toxicol Appl Pharmacol; 2008 May; 228(3):364-77. PubMed ID: 18295291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H1-antihistamines induce vacuolation in astrocytes through macroautophagy.
    Hu WW; Yang Y; Wang Z; Shen Z; Zhang XN; Wang GH; Chen Z
    Toxicol Appl Pharmacol; 2012 Apr; 260(2):115-23. PubMed ID: 22310178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vacuolar ATPase-mediated sequestration of local anesthetics in swollen macroautophagosomes.
    Bawolak MT; Morissette G; Marceau F
    Can J Anaesth; 2010 Mar; 57(3):230-9. PubMed ID: 20054683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of the vacuolar and macroautophagic cytopathology from the cytotoxicity induced by the lipophilic local anesthetic bupivacaine.
    Morissette G; Bawolak MT; Marceau F
    Can J Physiol Pharmacol; 2011 Jul; 89(7):505-12. PubMed ID: 21812528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vacuolar ATPase-mediated cellular concentration and retention of quinacrine: a model for the distribution of lipophilic cationic drugs to autophagic vacuoles.
    Marceau F; Bawolak MT; Bouthillier J; Morissette G
    Drug Metab Dispos; 2009 Dec; 37(12):2271-4. PubMed ID: 19773536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cation trapping by cellular acidic compartments: beyond the concept of lysosomotropic drugs.
    Marceau F; Bawolak MT; Lodge R; Bouthillier J; Gagné-Henley A; Gaudreault RC; Morissette G
    Toxicol Appl Pharmacol; 2012 Feb; 259(1):1-12. PubMed ID: 22198553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular sequestration of amiodarone: role of vacuolar ATPase and macroautophagic transition of the resulting vacuolar cytopathology.
    Morissette G; Ammoury A; Rusu D; Marguery MC; Lodge R; Poubelle PE; Marceau F
    Br J Pharmacol; 2009 Aug; 157(8):1531-40. PubMed ID: 19594752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of cation trapping by cellular acidic compartments.
    Marceau F; Roy C; Bouthillier J
    Methods Enzymol; 2014; 534():119-31. PubMed ID: 24359951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-substituted 4-aminobenzamides (procainamide analogs): an assessment of multiple cellular effects concerning ion trapping.
    Morissette G; Moreau E; C-Gaudreault R; Marceau F
    Mol Pharmacol; 2005 Dec; 68(6):1576-89. PubMed ID: 16183854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N(alpha)-imidazolylalkyl and pyridylalkyl derivatives of histaprodifen: synthesis and in vitro evaluation of highly potent histamine H(1)-receptor agonists.
    Menghin S; Pertz HH; Kramer K; Seifert R; Schunack W; Elz S
    J Med Chem; 2003 Dec; 46(25):5458-70. PubMed ID: 14640554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation by neuropeptide Y of histamine H1 receptor-mediated contraction in rat blood vessels.
    Piao H; Nagai S; Tsurumaki T; Niki T; Higuchi H
    Vascul Pharmacol; 2007 Apr; 46(4):260-70. PubMed ID: 17169617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of an H1 receptor-mediated, zinc-potentiated vasoconstrictor action of the histidyl dipeptide carnosine in rabbit saphenous vein.
    O'Dowd A; Miller DJ
    Br J Pharmacol; 1998 Nov; 125(6):1272-80. PubMed ID: 9863657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histamine H1-receptor antagonists inhibit nuclear factor-kappaB and activator protein-1 activities via H1-receptor-dependent and -independent mechanisms.
    Roumestan C; Henriquet C; Gougat C; Michel A; Bichon F; Portet K; Jaffuel D; Mathieu M
    Clin Exp Allergy; 2008 Jun; 38(6):947-56. PubMed ID: 18498541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple differences in agonist and antagonist pharmacology between human and guinea pig histamine H1-receptor.
    Seifert R; Wenzel-Seifert K; Burckstummer T; Pertz HH; Schunack W; Dove S; Buschauer A; Elz S
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1104-15. PubMed ID: 12626648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected partial H1-receptor agonism of imidazole-type histamine H3-receptor antagonists lacking a basic side chain.
    Sadek B; Elz S; Pertz HH; Stark H; Schunack W
    Inflamm Res; 2004 Aug; 53 Suppl 2():S109-15. PubMed ID: 15338060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High affinity capture and concentration of quinacrine in polymorphonuclear neutrophils via vacuolar ATPase-mediated ion trapping: comparison with other peripheral blood leukocytes and implications for the distribution of cationic drugs.
    Roy C; Gagné V; Fernandes MJ; Marceau F
    Toxicol Appl Pharmacol; 2013 Jul; 270(2):77-86. PubMed ID: 23603060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing ligand-specific histamine H1- and H2-receptor conformations with NG-acylated Imidazolylpropylguanidines.
    Xie SX; Ghorai P; Ye QZ; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2006 Apr; 317(1):139-46. PubMed ID: 16394198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N1-(3-cyclohexylbutanoyl)-N2-[3-(1H-imidazol-4-yl)propyl]guanidine (UR-AK57), a potent partial agonist for the human histamine H1- and H2-receptors.
    Xie SX; Kraus A; Ghorai P; Ye QZ; Elz S; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1262-8. PubMed ID: 16554355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.